Fulvestrant +/- Akt Inhibition in Advanced Aromatase Inhibitor Resistant Breast Cancer

NCT01992952 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

149

Enrollment

OTHER_GOV

Sponsor class

Conditions

Estrogen Receptor Positive Breast Cancer

Interventions

DRUG: AZD5363
DRUG: Placebo
DRUG: Fulvestrant

Sponsor

Velindre NHS Trust

Collaborators

AstraZeneca
Cenduit LLC
Covance
Cardiff and Vale University Health Board